Canadian Collaborating Clinical Trials Network supports faster, better cancer trials for patients
Official title: Canadian Cancer Trials Group - Canadian Collaborating Clinical Trials Network
Funded at Queen's University at Kingston · NIH-11291257 · Data updated 2026-11-12
A large, international cancer trials network is working with U.S. partners to run smarter, faster clinical trials so patients receive better, faster access to new therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Queen's University at Kingston NIH-funded |
| Lab location | 1 site (Kingston, Canada) |
| Project start | May 6, 2014 |
| Project end | February 29, 2032 |
| Funding year | 2026 |
| Award (this year) | $2,936,095 |
| NIH project number | 2U10CA180863-12 |
| Project ID | NIH-11291257 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with cancer in Canada or the U.S. who could enroll in multi-country cancer trials, including those with rare cancers or biomarker-defined subgroups.
✕Less likely to help
Patients without access to specialized centers or those not eligible for ongoing trials may see limited direct benefit.
What this research studies
This grant supports a network within Canada that collaborates with U.S. cancer trial groups to run high-quality trials. It focuses on expanding enrollment, sharing scientific expertise, and enabling international studies, including rare cancers and biomarker-defined groups. The aim is to accelerate the translation of scientific discoveries into real-world treatments for patients in both countries. The collaboration helps ensure diverse patient populations are represented and that trials can evaluate new immunotherapies, cellular therapies, and precision medicine approaches. This is about building the infrastructure and partnerships that make definitive, practice-changing trials possible.
Why it matters
Potential benefit: Patients could gain faster access to innovative therapies and more robust trial options through larger, more efficient international trials.
How similar studies have gone: Previous international collaborations have improved trial completion times and applicability of results across diverse populations.
Where this research is happening
-
Queen's University at Kingston
Kingston, Canada Active
Researchers
- Principal investigator: Dancey, Janet Ellen — Queen's University at Kingston
- Study coordinator: Dancey, Janet Ellen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.